Pip / Taz
Important information about the launch of Actavis generic Pipercillin/Tazobactam.
In order to comply with the risk minimisation measures agreed with the Medicines and Healthcare products Regulatory Agency (MHRA), we have produced the following documents:
1. Letter for Healthcare Professionals
This document summarises the main differences between the brand Tazocin® and the generic products. The text within this letter was drafted by the MHRA.
2. Poster for Healthcare Professionals
This document is intended for distribution and display in appropriate areas within the Trust including CIVAS units, nursing, clinical and pharmacy departments. This document is available on request in A3 hard copy.
3. Addendum to NHS IV Guide
Please incorporate the key points from this document into your IV Guide.
4. Question and Answer document
This document acts as a training brief for relevant NHS staff and supports items 1, 2 and 3 shown above.
To minimise the risk of incorrect administration or preparation of this product we ask that the enclosed materials are distributed to the necessary staff within your Trust, and that the pertinent points are incorporated into your clinical documents.
Please contact the commercial team at Actavis UK Ltd if you have any questions relating to this package of information on 01271 311200.
Download the Training Pack (PDF, 2,09MB)